These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vitro activity and beta-lactamase stability of a new penem, CGP 31608. Neu HC; Chin NX; Neu NM Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845 [TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates. Reimer LG; Mirrett S; Reller LB Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577 [TBL] [Abstract][Full Text] [Related]
10. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin. Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics. Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics. Perrymann F; Flournoy DJ; Qadri SM Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865 [TBL] [Abstract][Full Text] [Related]
14. In vitro studies of piperacilin, a new semisynthetic penicillin. Winston DJ; Wang D; Young LS; Martin WJ; Hewitt WL Antimicrob Agents Chemother; 1978 Jun; 13(6):944-50. PubMed ID: 677861 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi. Robinson RG; Saunders J; Cassel R; Block CS; Koornhof HJ Antimicrob Agents Chemother; 1980 Oct; 18(4):493-501. PubMed ID: 6449903 [TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams. Clarke AM; Zemcov SJ; Campbell ME J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of fosfomycin in vitro. Forsgren A; Walder M J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of HRE 664, a penem antibiotic. Chin XN; Neu HC Diagn Microbiol Infect Dis; 1990; 13(6):509-16. PubMed ID: 2279381 [TBL] [Abstract][Full Text] [Related]
19. [In vitro antibacterial activity of a new parenteral penem, sulopenem]. Yoshida T; Tateda E; Hiramatsu K; Yokota T Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624 [TBL] [Abstract][Full Text] [Related]
20. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Fu KP; Neu HC Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]